Pascale Sierra was appointed Director, Triveritas France in 2006. Triveritas is an international product development consultancy which has grown rapidly throughout Europe and North America and has offices in UK, France, and Germany. Triveritas provides specialist contract services to Animal Health and related companies. Triveritas develops veterinary vaccines and medicines by performing registration and regulatory maintenance, international trials, QA, project/study management, and training. A tailored start to finish service takes client projects from proof of concept through to multi-national registrations.
In line with her past experience, Pascale provides a service of regulatory advice for veterinary products, and she is also responsible for clinical project developments in France and Spain, in food – producing and companion animals. Previously, she spent 8 years in the veterinary industry, thus acquiring a broad experience in clinical research and regulatory affairs.
Pascale Sierra graduated as a veterinarian from the Maisons-Alfort School of Veterinary Medicine in 1995; and obtained her veterinary thesis with honours in 1997. In parallel, she passed degrees in physiology, parasitology and statistics applied to clinical research.
After a couple of years in small and large animal veterinary practice in France, she obtained a university degree to qualify for a position in the veterinary pharmaceutical industry. Pascale worked as a trainee in Clinical research for Virbac, then was employed at a CRO in France working in Clinical Research as a study monitor. Then, she moved to the UK and worked for Pfizer Animal Health as a Clinical Research Investigator for the following three years, getting experience in European-wide pharmaceutical development projects. She went back to France in 2002 and worked for Merial in Regulatory Affairs, managing European registrations for new veterinary medicines, and also regulatory support for registered products. Pascale was then appointed within Merial to manage the European clinical development of new veterinary medicines and vaccines.